ClinicalTrials HQ

Predictive Signature of Benralizumab Response

Predictive Signature of Benralizumab Response

Recruiting · NCT04565483 · Registry updated 2024-04-26
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Predictive Signature of Benralizumab ResponseEosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, obstructive lung disease, pulmonary eosinophilia, respiratory system disorderRecruitingPhase 42024-04-26NCT04565483

3 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
AstraZeneca806
Ministère de la Santé - France1
Nantes University Hospital223

20 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Assistance Publique des Hôpitaux de MarseilleMarseilleFrance1
Centre hospitalier Intercommunal Aix-en-ProvenceAix-en-ProvenceFrance1
CH MansLe MansFrance1
CHR OrléansOrléansFrance9
CHRU BrestBrestFrance21
CHU AngersAngersFrance87
CHU BordeauxBordeauxFrance67
CHU DijonDijonFrance37
CHU GrenobleGrenobleFrance48
CHU LilleLilleFrance63
CHU MontpellierMontpellierFrance56
CHU NantesNantesFrance86
CHU RouenRouenFrance49
CHU StrasbourgStrasbourgFrance31
CHU ToulouseToulouseFrance76
Hospices Civils de LyonLyonFrance43
Hôpital Bichat - AP-HPParisFrance1
Hôpital Bicêtre - AP-HPLe Kremlin-BicêtreFrance1
Hôpital FochSuresnesFrance27
Médipôle Hôpital Mutualiste de VilleurbanneVilleurbanneFrance1